190 related articles for article (PubMed ID: 29715131)
1. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring <3 cm.
Takagi Y; Matsuoka Y; Shiomi T; Nosaka K; Takeda C; Haruki T; Araki K; Taniguchi Y; Nakamura H; Umekita Y
Histopathology; 2015 Apr; 66(5):732-9. PubMed ID: 25322663
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas.
Takeda C; Takagi Y; Shiomi T; Nosaka K; Yamashita H; Osaki M; Endo K; Minamizaki T; Teshima R; Nagashima H; Umekita Y
Diagn Pathol; 2014 Oct; 9():205. PubMed ID: 25358722
[TBL] [Abstract][Full Text] [Related]
6. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.
Samejima J; Yokose T; Ito H; Nakayama H; Nagashima T; Suzuki M; Hamanaka R; Yamada K; Masuda M
Lung Cancer; 2019 Nov; 137():144-148. PubMed ID: 31593845
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
10. Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.
Frey A; Soubani AO; Adam AK; Sheng S; Pass HI; Lonardo F
Histopathology; 2009 Apr; 54(5):590-7. PubMed ID: 19309490
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma.
Lu M; Li J; Huang Z; Du Y; Jin S; Wang J
Med Sci Monit; 2016 Jan; 22():134-9. PubMed ID: 26757744
[TBL] [Abstract][Full Text] [Related]
12. Maspin expression patterns differ in the invasive versus lepidic growth pattern of pulmonary adenocarcinoma.
Lonardo F; Guan H; Dzinic S; Sheng S
Histopathology; 2014 Dec; 65(6):757-63. PubMed ID: 25040445
[TBL] [Abstract][Full Text] [Related]
13. Maspin expression is a favorable prognostic factor in non-small cell lung cancer.
Berardi R; Santinelli A; Onofri A; Brunelli A; Pierantoni C; Pisa E; Pagliacci A; Stramazzotti D; Zuccatosta L; Mazzanti P; Sabbatini A; Gasparini S; Bearzi I; Cascinu S
Anal Quant Cytol Histol; 2012 Apr; 34(2):72-8. PubMed ID: 22611762
[TBL] [Abstract][Full Text] [Related]
14. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications.
Lee DY; Park CS; Kim HS; Kim JY; Kim YC; Lee S
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):13-8. PubMed ID: 18091326
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
16. Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
Wakahara M; Sakabe T; Kubouchi Y; Hosoya K; Hirooka Y; Yurugi Y; Nosaka K; Shiomi T; Nakamura H; Umekita Y
Anticancer Res; 2017 Sep; 37(9):5071-5077. PubMed ID: 28870936
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic Maspin Expression Correlates with Poor Prognosis of Patients with Adenocarcinoma of the Uterine Cervix.
Nosaka K; Horie Y; Shiomi T; Itamochi H; Oishi T; Shimada M; Sato S; Sakabe T; Harada T; Umekita Y
Yonago Acta Med; 2015 Dec; 58(4):151-6. PubMed ID: 26740733
[TBL] [Abstract][Full Text] [Related]
18. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic-only Expression of Maspin Predicts Unfavorable Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
Uchinaka EI; Sakabe T; Hanaki T; Tokuyasu N; Sakamoto T; Honjo S; Fujiwara Y; Umekita Y
Anticancer Res; 2021 May; 41(5):2543-2552. PubMed ID: 33952482
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
